南美洲和中美洲医用酶技术市场预测至 2028 年 - COVID-19 影响和酶类型(消化酶、溶栓酶、水解酶和核酸内切酶)的区域分析;应用(疾病治疗、诊断工具、生物医学研究等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 146    |    Report Code: TIPRE00025042    |    Category: Life Sciences

South and Central America Medical Enzyme Technology Market

市场介绍

酶是植物、动物和微生物的活细胞中产生的蛋白质。所有生物体都需要酶来生长以及产生和利用生命所必需的能量。在活细胞中,酶充当催化剂,加速控制生命过程的化学反应。一百多年来,酶一直是重要的工业产品。然而,潜在的应用范围正在迅速扩大。随着重组 DNA 技术的出现,大量生产以前稀有的酶已成为可能,从而降低了成本。此外,在药品制造中,制造手性纯化合物的愿望正在带来新的机遇。技术进步促进了酶在越来越广泛的工艺条件下的使用。

因此,研究和开发活动的显着增加预计将在未来几年对医用酶技术产生巨大需求,预计这将进一步推动医用酶技术市场。

南美洲和中美洲的 COVID-19 病例正在增加。随着第二波COVID-19的爆发,拉丁美洲国家的病例数量有所增加。现在,国家正在日益扩大其临床服务以抗击新型冠状病毒。尽管存在这种影响,该地区的生物技术行业在抗击病毒方面却几乎没有采取任何行动,项目的缺乏暴露了该行业的脆弱性。有一些不相关的自主项目正在进行,但它们是彼此独立发生的,这意味着没有强大的生物技术网络。全球正在进行的数百个 COVID-19 疫苗或药物项目中的一小部分是在一个拥有超过 6.52 亿居民的地区和许多中等收入国家中进行的。目前,拉丁美洲只有 6 个独立生物技术项目正在研究 COVID-19,要么寻找疫苗,要么寻找治疗新型冠状病毒的方法。它们都不会进行临床试验。

 

市场概况和动态

南美洲和中美洲的医用酶技术市场预计将从2021年的2.793亿美元增长到2028年的4.121亿美元;预计 2021 年至 2028 年复合年增长率为 5.7%。生物制药是制药和生物技术行业不断增长的业务领域之一。自 1982 年推出以来,生物制药彻底改变了多种疾病的治疗方法,并且越来越多地应用于几乎所有医学分支。尽管需要投入大量时间和资金,生物制药市场仍在快速增长。

 

关键细分市场

从酶类型来看,2020年南美洲和中美洲医用酶技术市场中水解酶领域占据最大份额。从应用领域来看,疾病治疗领域占据最大份额。 2020年南美洲和中美洲医用酶技术市场。

 

主要来源和上市公司

准备本南美洲和中美洲医用酶技术市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Merck Kgaa、Thermo Fisher Scientific Inc.、Novozymes、Takeda Pharmaceutical Company Limited、Agilent Technologies, Inc.、Genzyme Corporation、Asahi Kasei Corporation、Promega Corporation、Cytiva 和 Amano Enzyme Inc.

 

< span>购买报告的理由

  • 了解南美洲和中美洲医用酶技术市场格局并确定细分市场最有可能保证丰厚的回报
  • 通过了解南美洲和中美洲医学酶技术市场不断变化的竞争格局,保持领先地位
  • 有效规划并购和合作伙伴关系通过识别最有前景的可能销售的细分市场,在南美洲和中美洲医疗酶技术市场进行交易
  • 通过对南美洲和中美洲医疗各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策酶技术市场
  • 获取南美洲和中美洲地区2021-2028年各细分市场的市场收入预测

 

南美洲和中美洲医用酶技术市场细分

按酶类型

  • 消化酶
    • L-天冬酰胺酶
    • 乳糖酶
    • 其他
  • 溶栓酶
    • 链激酶
    • 尿激酶
    • 其他
  • 水解酶
    • 透明质酸酶
    • 溶菌酶
    • 其他
  • 核酸内切酶
    • Benzonase
    • 其他

 

按申请

  • 疾病治疗
  • 诊断工具
  • 生物医学研究
  • 其他

 

按国家/地区

  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区< /span>

 

提及的公司

  1. Merck Kgaa
  2. Thermo Fisher Scientific Inc.
  3. Novozymes
  4. 武田制药有限公司
  5. 安捷伦科技公司,
  6. 健赞公司
  7. 旭化成公司
  8. Promega公司
  9. Cytiva
  10. 天野酶公司< /li>

 

 

South and Central America Medical Enzyme Technology Strategic Insights

Strategic insights for South and Central America Medical Enzyme Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-medical-enzyme-technology-market-strategic-framework.webp
Get more information on this report

South and Central America Medical Enzyme Technology Report Scope

Report Attribute Details
Market size in 2021 US$ 279.3 Million
Market Size by 2028 US$ 412.1 Million
Global CAGR (2021 - 2028) 5.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 酶类型
  • 消化酶
  • 血栓溶解酶
  • 水解酶
  • 核酸内切酶
By 应用
  • 疾病治疗
  • 诊断工具
  • 生物医学研究
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Merck Kgaa
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • Takeda Pharmaceutical Company Limited
  • Agilent Technologies, Inc.
  • Genzyme Corporation
  • Asahi Kasei Corporation
  • Promega Corporation
  • Cytiva
  • Amano Enzyme Inc.
  • Get more information on this report

    South and Central America Medical Enzyme Technology Regional Insights

    The regional scope of South and Central America Medical Enzyme Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-medical-enzyme-technology-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Medical Enzyme Technology Market

    1. Merck Kgaa
    2. Thermo Fisher Scientific Inc.
    3. Novozymes
    4. Takeda Pharmaceutical Company Limited
    5. Agilent Technologies, Inc.
    6. Genzyme Corporation
    7. Asahi Kasei Corporation
    8. Promega Corporation
    9. Cytiva
    10. Amano Enzyme Inc.        
    Frequently Asked Questions
    How big is the South and Central America Medical Enzyme Technology Market?

    The South and Central America Medical Enzyme Technology Market is valued at US$ 279.3 Million in 2021, it is projected to reach US$ 412.1 Million by 2028.

    What is the CAGR for South and Central America Medical Enzyme Technology Market by (2021 - 2028)?

    As per our report South and Central America Medical Enzyme Technology Market, the market size is valued at US$ 279.3 Million in 2021, projecting it to reach US$ 412.1 Million by 2028. This translates to a CAGR of approximately 5.7% during the forecast period.

    What segments are covered in this report?

    The South and Central America Medical Enzyme Technology Market report typically cover these key segments-

  • 酶类型 (消化酶, 血栓溶解酶, 水解酶, 核酸内切酶)
  • 应用 (疾病治疗, 诊断工具, 生物医学研究)
  • What is the historic period, base year, and forecast period taken for South and Central America Medical Enzyme Technology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Medical Enzyme Technology Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South and Central America Medical Enzyme Technology Market?

    The South and Central America Medical Enzyme Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck Kgaa
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • Takeda Pharmaceutical Company Limited
  • Agilent Technologies, Inc.
  • Genzyme Corporation
  • Asahi Kasei Corporation
  • Promega Corporation
  • Cytiva
  • Amano Enzyme Inc.
  • Who should buy this report?

    The South and Central America Medical Enzyme Technology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Medical Enzyme Technology Market value chain can benefit from the information contained in a comprehensive market report.